Posts

Showing posts with the label Neurostimulation Devices Market Size

Neurostimulation Devices Market Share And Rising Demand With CAGR Of 12.5% For The Forecast Period From 2019-2026 : Grand View Research Inc.

San Francisco, 26 August 2019:  The Report   Neurostimulation Devices Market   Size, Share & Trends Analysis Report By Application (Pain Management, Urinary & Fecal Incontinence, Epilepsy), By Product (Spinal Cord, Deep Brain Stimulators), And Segment Forecasts, 2019 - 2026 The global neurostimulation devices market size is expected to reach USD 12.6 billion by 2026 registering a CAGR of 12.5%, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases, such as migraine and epilepsy, due to unhealthy diet and lifestyle and rising geriatric population is expected to be the major growth-driving factor for the neurostimulation devices market. However, adverse effects and risks associated with neurostimulation devices and stringent regulations regarding product approval are expected to hamper the growth. Increasing incidence of Road Traffic Accidents (RTAs) is another factor driving the product demand. Moreover, manufacturers are investing

Neurostimulation Devices Market To Expand Industry Growth At USD 9.8 Billion By 2024 : Grand View Research Inc.

San Francisco, 21 May 2019:  The Report  Neurostimulation Devices Market  Size, Share & Trend Analysis By Product (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator), By Application, And Segment Forecasts, 2018 – 2024 The Neurostimulation Devices Market is expected to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. The neurostimulation devices market is anticipated to witness a significant growth during the study period from 2016 to 2024. This growth is majorly attributed to high prevalence of chronic diseases, including migraine and epilepsy. Increasing adoption of unhealthy lifestyle, diet, and growth in aging population is resulting in a growing incidence of the chronic disease in individuals. However, adverse effects and risks associated with neurostimulation devices and presence of stringent device approval regulations are expected to hamper the growth. Apart from the above mentioned factors, increasing incidence